The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
Maringá Post · Aug 31, 2026
Endocrinologista explica que a preservação da massa magra atua como órgão endócrino essencial para autonomia e saúde na velhice, reduzindo riscos de doenças neurodegenerativas.
Jornal da Paraíba · Aug 31, 2026
O SUS disponibilizará a partir de outubro brigatinibe, gefitinibe e durvalumabe para tratamento de câncer de pulmão, medicamentos de alta tecnologia que custam até R$ 643 mil na rede privada.
PerthNow · Aug 31, 2026
Democratic Republic of Congo reports 6041 confirmed Ebola cases with 2911 deaths, marking the largest outbreak in the country's history caused by the Bundibugyo strain.
R7 · Aug 31, 2026
A Anvisa aprovou o registro do Yluméc, nova caneta emagrecedora produzida pela EMS com semaglutida, classificada como medicamento similar ao Ozivy para tratamento de diabetes tipo 2.
Google News · Aug 31, 2026
Utah County has confirmed its first human case of West Nile virus, identified as the more dangerous neuroinvasive strain. This marks the 12th case in Utah this year.
El Confidencial · Aug 31, 2026
Investigadores de la Universidad de Colorado Boulder han desarrollado un material con subsuperficies fonónicas que reduce la resistencia aerodinámica mediante vibraciones microscópicas, abordando un problema creciente en la aviación moderna.
GZH · Aug 31, 2026
Hospital em Passo Fundo utiliza técnica menos invasiva para tratar varizes, doença vascular que afeta 30% da população, durante campanha de conscientização em agosto.
Google News · Aug 31, 2026
Medical experts recommend lifestyle modifications and dietary changes over supplements to support brain health and reduce Alzheimer's risk, ahead of World Alzheimer's Month.
ISTOÉ Independente · Aug 31, 2026
A Anvisa aprovou o Yluméc, caneta injetável de semaglutida desenvolvida pela EMS para tratamento de diabetes tipo 2, expandindo a concorrência neste mercado no Brasil.
Paraíba Online · Aug 31, 2026
A Anvisa aprovou o registro do Yluméc, nova caneta emagrecedora com semaglutida produzida pela EMS, após expiração da patente do Ozempic.
Meio Norte · Aug 31, 2026
A Anvisa aprovou o Yluméc, medicamento à base de semaglutida produzido pela EMS para tratamento de diabetes tipo 2, após expiração da patente do Ozempic.
Jornal de Notícias · Aug 31, 2026
A ULS do Nordeste realizou a primeira cirurgia robótica à coluna vertebral com equipamento de 2,6 milhões de euros financiado pelo PRR, oferecendo maior precisão e menor exposição à radiação.
Google News · Aug 31, 2026
Medical experts clarify misconceptions about prostate cancer, emphasizing that unremarkable findings are positive outcomes. Multiple sources provide guidance on screening, risk assessment, and treatment options for men.
Lokmat Times · Aug 31, 2026
Bangladesh's measles outbreak has claimed nearly 1000 lives in 2026, with 973 confirmed and suspected deaths reported as of August 31. The crisis stems from vaccine supply disruptions and missed immunization programs during 2024-2025.
O Tempo · Aug 31, 2026
A Anvisa aprovou o registro do Yluméc, medicamento à base de semaglutida da EMS para tratamento de diabetes tipo 2, expandindo as opções disponíveis no mercado após a queda da patente.
Google News · Aug 31, 2026
A Richmond, Virginia woman woke to discover a bat attempting to crawl into her mouth, prompting warnings about rabies risk and wildlife safety precautions.
Google News · Aug 31, 2026
Oncologists warn that certain coffee creamers may increase cancer risk, offering alternative recommendations for consumers concerned about their daily coffee habits.
Google News · Aug 31, 2026
NYC Health Department is spraying pesticides across multiple neighborhoods including Boro Park and Upper West Side to combat West Nile virus, which has been reported across four boroughs.
Veja · Aug 31, 2026
A Anvisa aprovou o Yluméc, medicamento similar à base de semaglutida da EMS para tratamento de diabetes tipo 2. A aprovação amplia opções de terapia injetável fabricada no Brasil.
Olhar Digital · Aug 31, 2026
A Anvisa aprovou o Yluméc, nova caneta de semaglutida da EMS para diabetes tipo 2, classificado como similar do Ozivy. O medicamento aguarda aprovação de preço pela CMED antes de chegar às farmácias.
Google News · Aug 31, 2026
Multiple US states report increasing vaccination exemption rates among kindergarteners, with some regions seeing 13% of children lacking standard vaccinations amid measles outbreak concerns.
Google News · Aug 31, 2026
Scientists have identified biological mechanisms explaining why liver damage may persist even after patients stop drinking alcohol, offering insights into chronic liver disease progression.
Google News · Aug 31, 2026
A newly approved pancreatic cancer drug priced at $480,000 annually exemplifies escalating cancer medication costs, sparking debate over drug pricing sustainability and access.
Google News · Aug 31, 2026
Women are frequently prescribed antibiotics for urinary tract infections they don't actually have, contributing to antibiotic resistance and unnecessary treatment.